DoW Reconstructive Transplant, Investigator-Initiated Research Award
This grant funds investigator-initiated research in reconstructive transplant with military relevance, supporting basic to translational studies (excluding clinical trials) that aim to improve patient care and quality of life.
Funder: Defense Health Agency Contracting Activity - DHACA
Due Dates: October 21, 2026 (Pre-Application/LOI) | November 4, 2026 (Full Application) | November 9, 2026 (End of Verification)
Funding Amounts: Total program funding: $8M; up to $1M total costs per award for up to 3 years; ~8 awards expected.
Summary: Supports investigator-initiated research projects with military-relevant utility to advance reconstructive transplant science, excluding clinical trials.
Key Information: Clinical trials are not allowed; preliminary data are required; open to all organization types.
Description
This opportunity supports investigator-initiated research that advances the field of reconstructive transplantation, with a strong emphasis on projects that address the needs of military service members, veterans recovering from traumatic injury, and their families or caregivers. Projects may cover any research phase from basic science to translational studies (including preclinical animal models and clinical research involving human subjects or anatomical substances), but clinical trials are not permitted. Proposals must be scientifically rigorous, include relevant preliminary or published data, and demonstrate clear military relevance. Research must address at least one of the program’s focus areas, such as immunosuppression, graft monitoring, biomarker development, or outcome measurement for vascularized composite allotransplantation (VCA).
